Pharma breakthrough! BioIntelect to revolutionise trials using Opyl’s cutting-edge tech
In a landmark collaboration, Opyl Limited announced a new six-month agreement with BioIntelect, a renowned Clinical Research Organisation (CRO) and strategic consulting firm in the ... Read More
Opyl Limited announces divestment of Opin to focus on AI-driven clinical trial management
Opyl Limited, listed on the Australian Securities Exchange under the ticker ASX:OPL, has entered a significant phase of corporate restructuring with the announcement of a ... Read More